Patch pump is finally here

The Melbourne, Australia based company Phosphagenics have finally annouced the first set of human trials for its TPM/insulin patch pump.

Ina press release published by the company, they indicate that a human trial has already completed proving the basic technology can deliver insulin to people with Type 1 diabetes.

According to Dr Esra Ogru, COO, the ability of the Phosphagenics’ TPM technology to deliver large proteins, such as insulin, through the skin and into the blood stream “has potential to reduce the number of invasive injections per day,” she said. “Our aim is to provide a basal level of insulin to people with diabetes over a sustained period. Currently basal levels of insulin are provided by injections. Basal insulin is the fastest growing segment of the insulin market.”

I can only hope that this time we actually get beyond the research and into a final product. We seem to have heard too many times that this type of technology is about to get into the market but we are still waiting.

Share

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: